Recurrent glioblastoma multiforme... [Expert Rev Anticancer Ther. 2006] - PubMed

loading

Bevacizumab antiangiogenic therapy for glioblastoma. [Neurology. 2011]
Bevacizumab antiangiogenic therapy for glioblastoma.
Junck L. Neurology. 2011 Feb 1; 76(5):414-5.
Review Novel chemotherapeutic agents for the treatment of glioblastoma multiforme. [Expert Opin Investig Drugs. 2003]
Review Novel chemotherapeutic agents for the treatment of glioblastoma multiforme.
Jendrossek V, Belka C, Bamberg M. Expert Opin Investig Drugs. 2003 Dec; 12(12):1899-924.
Review Topoisomerase I inhibitors for the treatment of brain tumors. [Expert Rev Anticancer Ther. 2008]
Review Topoisomerase I inhibitors for the treatment of brain tumors.
Feun L, Savaraj N. Expert Rev Anticancer Ther. 2008 May; 8(5):707-16.
Review Evolving strategies: future treatment of glioblastoma. [Expert Rev Neurother. 2011]
Review Evolving strategies: future treatment of glioblastoma.
Chamberlain M. Expert Rev Neurother. 2011 Apr; 11(4):519-32.
Fewer dollars, more sense. [J Clin Oncol. 2008]
Fewer dollars, more sense.
Garfield DH, Hercbergs A. J Clin Oncol. 2008 Nov 10; 26(32):5304-5; author reply 5305. Epub 2008 Oct 14.

Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas. [Core Evid. 2010]
Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas.
Omar AI, Mason WP. Core Evid. 2010 Jun 15; 4:93-111. Epub 2010 Jun 15.
Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity. [Mol Ther. 2008]
Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity.
Allen C, Paraskevakou G, Iankov I, Giannini C, Schroeder M, Sarkaria J, Schroeder M, Puri RK, Russell SJ, Galanis E. Mol Ther. 2008 Sep; 16(9):1556-64. Epub 2008 Jul 29.
Review Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy. [Expert Opin Biol Ther. 2008]
Review Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy.
Reardon DA, Wen PY, Desjardins A, Batchelor TT, Vredenburgh JJ. Expert Opin Biol Ther. 2008 Apr; 8(4):541-53.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recurrent glioblastoma multiforme: advances in treatment and promising drug cand...
Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.
Expert Rev Anticancer Ther. 2006 Nov ;6(11):1593-607.

PubMed
Molecular pathogenesis of primary central nervous system lymphoma.
Molecular pathogenesis of primary central nervous system lymphoma.
Neurosurg Focus. 2006 Nov 15 ;21(5):E1.

PubMed
Impact of silanol surface density on the toxicity of silica aerosols measured by...
Impact of silanol surface density on the toxicity of silica aerosols measured by erythrocyte haemolysis.
J Occup Environ Hyg. 2006 Dec ;3(12):718-23.

PubMed
[Methodological aspects of current research in the areas of biosynthesis and rol...
[Methodological aspects of current research in the areas of biosynthesis and roles of intercellular substance proteins (review)].
Vopr Med Khim. 1991 Jan-Feb ;37(1):2-8.

PubMed
Re: Why omega-3 fatty acids are important to neurosurgeons (Ausman JI, Surg Neur...
Re: Why omega-3 fatty acids are important to neurosurgeons (Ausman JI, Surg Neurol 2006;65:325). Omega-3 fatty acids (fish oil) as an anti-inflammatory: an alternative to NSAIDs for discogenic pain (Maroon JC and Bost JW, Surg Neurol 2006;65:326-31).
Surg Neurol. 2006 Nov ;66(5):552; author reply 552-3.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed